Antin reports first-half revenue decline on lower fees

Antin reported first-half 2026 revenue of €138.5 million, down 4.5% year over year, while adjusted EPS declined 14.9% and adjusted net income totaled €47 million. Adjusted EBITDA was €69.9 million, maintaining a 50% margin, but management expects full-year 2026 underlying EBITDA to be slightly below 2025 as Mid Cap I fee generation shifts to invested rather than committed capital. The firm maintained its expected €0.71 full-year dividend and approved a €0.28 interim dividend, with Mid Cap II activation anticipated in Q4 2026.

Analysis

ANTIN is entering the least attractive portion of the private-markets fee cycle: legacy-fund step-downs create operating deleverage before a successor vehicle begins contributing meaningful fee revenue. Because the cost base is predominantly compensation and fundraising infrastructure, even modest fee-rate pressure can translate into disproportionately weaker EPS and reduce the premium multiple typically afforded to asset-light alternative managers. The key issue is not the current earnings miss, but whether Mid Cap II reaches sufficient scale and closes on schedule to offset run-off during 2027.

A stable dividend may support the shares near term, but it also raises the hurdle for balance-sheet flexibility if fundraising is delayed or realizations remain weak. In a slower exit environment, carried-interest recovery is unlikely to be a reliable earnings catalyst; therefore, the market should value ANTIN primarily on recurring fee-related earnings and net inflows rather than headline EBITDA. Listed alternatives with broader product suites and more perpetual capital, including EQT AB (EQT SS) and Brookfield Asset Management (BAM), should command relatively better earnings visibility.

The contrarian case is that this is an identifiable, rather than structural, fee trough: infrastructure fundraising remains supported by energy-transition, digital-network and reshoring capex, and a successful Mid Cap II activation could cause investors to capitalize 2027 fee-related earnings well before reported revenue inflects. That upside requires independently confirming fund size, first-close commitments, deployment pace and management-fee terms; without those data, the dividend alone is insufficient evidence of a bargain.

Key Decisions for Investors

• Maintain an underweight/avoid new ANTIN exposure through the Mid Cap II activation window in Q4 2026; the next 1-3 month catalyst path is more likely estimate cuts or muted fundraising commentary than an earnings re-rating.
• Set a buy alert only if ANTIN discloses a first close for Mid Cap II at a scale capable of replacing legacy fee run-off and reiterates 2027 fee-related earnings growth. A credible close would support a 6-18 month long thesis; failure to activate in Q4 is thesis-falsifying and warrants avoiding the name.
• For relative exposure to infrastructure/private-markets fundraising, favor long EQT SS or BAM versus short ANTIN in equal euro notional over 3-6 months. The trade expresses superior recurring-capital and product-diversification economics while limiting broad multiple-expansion risk in alternatives.
• Monitor dividend coverage against recurring fee-related earnings rather than total reported profit. Any need to fund the payout through balance-sheet cash, or guidance for another year of declining underlying EBITDA, would increase downside risk through both earnings and yield-premium compression.